| Date Filed | Type | Description |
| 08/03/2022 |
4
| Hoffman Robert E. (President and CEO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 400,145 shares
@ $0
Granted 1,200,634 options to buy
@ $0.1757, valued at
$211k
|
|
| 02/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2021 |
4
| HOFFMAN ROBERT (President and CEO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 3,519,170 options to buy
@ $0.96, valued at
$3.4M
|
|
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| HOFFMAN ROBERT (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,000 options to buy
@ $21.54, valued at
$495.4k
|
|
| 09/17/2020 |
4
| HOFFMAN ROBERT (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 120,000 options to buy
@ $1.7, valued at
$204k
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2020 |
4
| HOFFMAN ROBERT (Former Director) has filed a Form 4 on Aravive, Inc. |
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2019 |
4
| HOFFMAN ROBERT (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 7,500 options
@ $5.77, valued at
$43.3k
|
|
| 09/09/2019 |
4
| HOFFMAN ROBERT (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Granted 39,567 options to buy
@ $0.61, valued at
$24.1k
Granted 35,433 options to buy
@ $0.61, valued at
$21.6k
|
|
| 06/27/2019 |
4
| HOFFMAN ROBERT (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 13,000 options to buy
@ $19.55, valued at
$254.2k
|
|
| 05/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2019 |
4/A
| HOFFMAN ROBERT (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 7,500 options
@ $0
Granted 4,688 options
@ $0 |
|
| 01/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2018 |
4
| HOFFMAN ROBERT (CFO & SVP, Finance) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 71,000 options to buy
@ $24.97, valued at
$1.8M
|
|
| 11/13/2018 |
4
| HOFFMAN ROBERT (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.6099, valued at
$24.4k
|
|
| 10/16/2018 |
3
| HOFFMAN ROBERT (Director) has filed a Form 3 on Aravive, Inc. |
| 07/03/2018 |
4
| HOFFMAN ROBERT (CFO & SVP, Finance) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 744 shares
@ $13.2175, valued at
$9.8k
Sold 28,940 shares
@ $38.1516, valued at
$1.1M
Sold 1,060 shares
@ $38.7953, valued at
$41.1k
Exercised 30,000 options to buy
@ $15.3, valued at
$459k
|
|
| 06/08/2018 |
4
| HOFFMAN ROBERT (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 13,000 options to buy
@ $16.35, valued at
$212.6k
|
|
| 04/17/2018 |
4
| HOFFMAN ROBERT (Director) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Granted 36,000 options to buy
@ $1.06, valued at
$38.2k
Granted 200,000 rights
@ $0 |
|
| 04/12/2018 |
3
| HOFFMAN ROBERT (Director) has filed a Form 3 on DelMar Pharmaceuticals, Inc. |
| 12/20/2017 |
4
| HOFFMAN ROBERT (CFO & SVP, Finance) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 536 shares
@ $13.0475, valued at
$7k
Granted 56,667 options to buy
@ $17, valued at
$963.3k
|
|
| 11/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2017 |
4
| HOFFMAN ROBERT (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 10,000 options to buy
@ $8.6, valued at
$86k
|
|
| 05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/24/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/07/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 08/30/2016 |
4
| HOFFMAN ROBERT (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 4,100 options to buy
@ $5, valued at
$20.5k
|
|
|